id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_4k74kvxnzrclnjhdno4jlodxqq	Amish Vora	Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer	2018.0		.pdf	text/html	838	147	57	Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer | Semantic Scholar Corpus ID: 14015493Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer title={Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer}, Optimization of adjuvant systemic therapy in women with early-stage hormone receptor-positive breast cancer includes the consideration of chemotherapy and duration of hormone therapy. Adjuvant hormonal therapy significantly improves long-term survival of breast cancer patients with hormone receptor-positive disease. Tables and Topics from this paper Sort by Most Influenced Papers American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Use of tamoxifen for breast cancer: twenty-eight years later. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer.	./cache/work_4k74kvxnzrclnjhdno4jlodxqq.pdf	./txt/work_4k74kvxnzrclnjhdno4jlodxqq.txt